Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

ADVA Optical Networking Turns To Profit In Q1 - Quick Facts

ADVA Optical Networking (ADVOF.PK) reported IFRS net income of 4 million euros or 0.08 euros per share versus loss of 2.3 million euros or 0.05 euros per share last year.

Quarterly revenues improved to 81.7 million euros from 70.4 million euros in the prior year.

Looking forward, the company said while the fragile global economy still demands a cautious sentiment, it expects second quarter 2012 revenues to be between 81 million euros and 86 million euros. Further, ADVA Optical Networking anticipates second-quarter pro forma operating income to range between 3% and 7% of revenues.

Click here to receive FREE breaking news email alerts for ADVA Optical Networking and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks have fluctuated over the course of the trading day on Thursday, as traders continue to digest yesterday's monetary policy announcement from the Federal Reserve as well as better than expected third quarter GDP data. Hundreds of protesters stormed Burkina Faso's parliament on Thursday and set fire to the building, preventing the lawmakers from considering a bill to extend the president's 27-year rule. Security forces opened fire on protesters, as they looted computers and televisions in the National Assembly, news agencies reported. The angry crowd then marched towards the President's office, before they were U.S. economic activity increased by more than expected in the third quarter of 2014, according to a report released by the Commerce Department on Thursday. The Commerce Department said GDP increased by 3.5 percent in the third quarter compared to 3.0 percent growth expected by economists.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.